MORLAND HOUSE SURGERY — All Prescriptions & Medications — Page 4
Practice Code: K84014 | OXFORD, OX33 1DP
Showing results 151-200 of 624
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lithium carbonate | 270 | 6,944 | £1.0K | +112.8% ▲ |
| Timolol | 270 | 5,635 | £1.6K | +205.3% ▲ |
| Tolterodine | 268 | 9,688 | £681 | +80.3% ▲ |
| Tadalafil | 268 | 3,946 | £1.1K | +57.6% ▲ |
| Insulin glargine | 267 | 1,400 | £11.6K | -6.0% ▼ |
| Nefopam hydrochloride | 265 | 19.5K | £901 | +134.3% ▲ |
| Tiotropium bromide | 259 | 2,219 | £5.8K | -14.8% ▼ |
| Loratadine | 257 | 13.0K | £323 | +23.0% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 255 | 9,297 | £842 | +67.0% ▲ |
| Other emollient preparations | 255 | 134.4K | £1.7K | -57.5% ▼ |
| 251 | 251 | £11.1K | -19.2% ▼ | |
| Olanzapine | 250 | 8,211 | £725 | -32.5% ▼ |
| 246 | 271 | £1.4K | +4.1% ▲ | |
| Mebeverine hydrochloride | 245 | 13.8K | £469 | -21.1% ▼ |
| Fluticasone furoate | 245 | 251 | £1.7K | +26.5% ▲ |
| Timolol and bimatoprost | 241 | 4,506 | £4.1K | +58.8% ▲ |
| Mometasone furoate | 241 | 18.0K | £1.6K | +80.2% ▲ |
| Sodium valproate | 240 | 53.4K | £3.7K | -24.5% ▼ |
| Ferrous sulfate | 233 | 5,114 | £180 | -54.7% ▼ |
| Tirzepatide | 223 | 236 | £22.3K | +14.8% ▲ |
| Sacubitril/valsartan | 218 | 10.1K | £16.6K | -9.0% ▼ |
| Hydrocortisone | 218 | 8,704 | £1.2K | +158.2% ▲ |
| Pivmecillinam hydrochloride | 214 | 3,664 | £1.9K | +307.6% ▲ |
| 208 | 26.9K | £1.1K | +58.8% ▲ | |
| Ropinirole hydrochloride | 206 | 10.7K | £7.1K | +93.9% ▲ |
| Lorazepam | 205 | 5,687 | £2.5K | +43.8% ▲ |
| Calcipotriol | 205 | 15.8K | £10.9K | +20.4% ▲ |
| Denosumab | 204 | 204 | £36.2K | +649.6% ▲ |
| Tamoxifen citrate | 204 | 6,360 | £1.0K | +147.7% ▲ |
| Sodium bicarbonate | 204 | 11.4K | £528 | +120.7% ▲ |
| Dexamethasone | 204 | 1,100 | £686 | +18.6% ▲ |
| Pancreatin | 202 | 65.3K | £18.4K | +81.7% ▲ |
| Vitamin B compound | 201 | 4,984 | £335 | +44.3% ▲ |
| Hypromellose | 201 | 2,180 | £140 | +51.7% ▲ |
| Rivaroxaban | 200 | 3,362 | £2.0K | -67.3% ▼ |
| Cyclizine hydrochloride | 200 | 9,972 | £373 | +24.0% ▲ |
| Fluticasone/umeclidinium/vilanterol | 197 | 198 | £8.4K | -16.0% ▼ |
| 196 | 1,987 | £877 | -21.4% ▼ | |
| Fenofibrate | 195 | 3,777 | £439 | +101.5% ▲ |
| Glyceryl trinitrate | 191 | 1,381 | £503 | -19.2% ▼ |
| Promethazine hydrochloride | 191 | 7,774 | £938 | -46.6% ▼ |
| Combined ethinylestradiol 20mcg | 191 | 11.1K | £1.8K | +265.6% ▲ |
| Dorzolamide | 188 | 6,390 | £3.0K | +126.2% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 187 | 21.1K | £1.2K | -17.3% ▼ |
| 187 | 17.2K | £799 | +244.5% ▲ | |
| Sulfasalazine | 185 | 15.4K | £2.1K | +42.1% ▲ |
| Trimethoprim | 185 | 5,676 | £353 | -9.5% ▼ |
| Bempedoic acid/Ezetimibe | 184 | 5,152 | £9.7K | +201.3% ▲ |
| Carbomer 940/980 | 184 | 2,540 | £538 | +20.8% ▲ |
| Pantoprazole | 183 | 8,036 | £369 | -33.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.